Zini Tanzi, Gina
 Distribuzione geografica
Continente #
EU - Europa 5.052
NA - Nord America 4.213
AS - Asia 2.754
SA - Sud America 633
AF - Africa 80
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.746
Nazione #
US - Stati Uniti d'America 4.094
DE - Germania 1.780
SG - Singapore 1.234
IT - Italia 1.195
CN - Cina 844
SE - Svezia 530
BR - Brasile 529
GB - Regno Unito 291
UA - Ucraina 291
FR - Francia 251
IE - Irlanda 159
ID - Indonesia 134
FI - Finlandia 131
PL - Polonia 130
IN - India 120
VN - Vietnam 105
RU - Federazione Russa 71
CA - Canada 58
NL - Olanda 57
TR - Turchia 50
AR - Argentina 40
BE - Belgio 40
HK - Hong Kong 36
MX - Messico 36
JP - Giappone 31
BD - Bangladesh 25
IQ - Iraq 25
AT - Austria 19
ES - Italia 19
ZA - Sudafrica 19
EC - Ecuador 17
PK - Pakistan 17
PE - Perù 16
IR - Iran 14
CI - Costa d'Avorio 13
LT - Lituania 13
CH - Svizzera 12
PT - Portogallo 12
SA - Arabia Saudita 12
MA - Marocco 11
JO - Giordania 10
KR - Corea 10
AU - Australia 9
CO - Colombia 9
CZ - Repubblica Ceca 9
IL - Israele 9
KE - Kenya 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
RO - Romania 8
UZ - Uzbekistan 8
VE - Venezuela 7
DZ - Algeria 6
GE - Georgia 6
MY - Malesia 6
CL - Cile 5
DO - Repubblica Dominicana 5
EE - Estonia 5
EG - Egitto 5
KG - Kirghizistan 5
KZ - Kazakistan 5
BH - Bahrain 4
DK - Danimarca 4
ET - Etiopia 4
GR - Grecia 4
LB - Libano 4
NO - Norvegia 4
PY - Paraguay 4
YE - Yemen 4
AM - Armenia 3
BZ - Belize 3
NG - Nigeria 3
PA - Panama 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
HN - Honduras 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
EU - Europa 1
GI - Gibilterra 1
Totale 12.727
Città #
Chandler 647
Singapore 511
Ashburn 366
Jacksonville 195
Beijing 186
San Mateo 174
Ann Arbor 169
Dublin 158
Dearborn 148
Nanjing 144
Milan 132
Rome 117
Los Angeles 113
Jakarta 112
Warsaw 109
Nürnberg 105
Munich 83
Woodbridge 82
Cattolica 81
Dallas 79
New York 79
Wilmington 78
Boston 71
Lawrence 66
Frankfurt am Main 63
Redmond 60
Fairfield 58
Houston 57
Seattle 56
Bremen 55
Nanchang 53
Redwood City 50
São Paulo 50
Hefei 49
Marseille 49
Lancaster 47
Moscow 39
Brussels 38
Hangzhou 34
Helsinki 32
Hong Kong 32
The Dalles 32
Naples 30
Hanoi 29
Izmir 29
Ho Chi Minh City 28
Norwalk 27
Leawood 25
London 25
Mountain View 25
Princeton 25
Shenyang 25
Boardman 24
Toronto 24
Zhengzhou 24
Chicago 23
Buffalo 22
Kunming 22
Rio de Janeiro 22
Shanghai 21
Florence 20
Tianjin 20
Turin 20
Turku 20
Guangzhou 19
Jiaxing 19
Palermo 19
Santa Clara 19
Tokyo 19
Brooklyn 18
Augusta 17
Columbus 17
Hebei 17
Düsseldorf 16
Cagliari 15
Pune 15
Cambridge 14
Falls Church 14
Hyderabad 14
San Francisco 14
University Park 14
Abidjan 13
Bologna 13
Genoa 13
Vienna 13
Baghdad 12
Bari 12
Brasília 12
Lima 12
Montreal 12
Las Vegas 11
Mexico City 11
Stockholm 11
Auburn Hills 10
Johannesburg 10
Kent 10
Mumbai 10
Nuremberg 10
Padova 10
Paris 10
Totale 5.884
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 977
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 348
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 328
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 303
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 280
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 270
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 252
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 208
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 201
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 195
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 191
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 190
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 185
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 185
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 173
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 164
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 161
Morphology of Blood Disorders 161
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 161
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 161
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 158
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 158
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 154
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 154
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 151
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 148
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 146
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 143
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 142
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 138
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 138
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 138
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 137
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 137
Analysis of bone marrow aspiration fluid using automated blood cell counters. 136
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 129
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 127
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 126
Allogeneic cord blood red cells for transfusion 126
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 125
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 123
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 120
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 118
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 115
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 114
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 112
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 111
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 107
Fechtner syndrome: report of a third family and literature review 102
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 102
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 102
the concomitance of lymphoma and breast carcinoma in the bone 99
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 98
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 97
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 96
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 96
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 95
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 95
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 94
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 91
Medicine use in pregnancy and public cord blood bank databases 90
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 90
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 89
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 87
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 87
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 86
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 86
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 86
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 83
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 82
Leukemia diagnosis: today and tomorrow 81
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 80
Diagnostics and prognostication of myelodysplastic syndromes 78
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 77
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 77
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 76
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 75
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 75
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 73
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 72
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 72
The concomitance of lymphoma and breast carcinoma in the bone 69
Case of metastatic melanoma in bone marrow smear 67
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 67
Innovation in hematology: Morphology and flow cytometry at the crossroads 66
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 63
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 62
ICSH: on board for new projects 61
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 59
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 57
Schistocytes 57
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 57
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 56
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 56
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 56
INTRODUCTION 54
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 52
Research in morphology and flow cytometry is at the heart of hematology 51
Totale 12.844
Categoria #
all - tutte 48.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 39 70 32 114 29 157 9
2021/2022957 82 91 22 49 77 37 30 163 36 52 132 186
2022/20231.880 214 261 146 289 139 234 78 169 238 28 51 33
2023/2024970 55 253 33 64 48 142 86 26 23 37 105 98
2024/20252.075 45 72 150 100 222 98 98 99 281 208 402 300
2025/20262.290 721 136 268 409 702 54 0 0 0 0 0 0
Totale 12.844